• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

淀粉样β肽差向异构体/异构体的抗体结合及其对免疫疗法和药物开发的影响。

Antibody binding of amyloid beta peptide epimers/isomers and ramifications for immunotherapies and drug development.

机构信息

Department of Chemistry and Biochemistry, The University of Texas at Arlington, Arlington, TX, 76019, USA.

出版信息

Sci Rep. 2023 Jul 31;13(1):12387. doi: 10.1038/s41598-023-38788-1.

DOI:10.1038/s41598-023-38788-1
PMID:37524807
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10390520/
Abstract

Extracellular deposition of amyloid beta (Aβ) peptide is a contributing factor of Alzheimer's disease (AD). Considerable effort has been expended to create effective antibodies, or immunotherapies, targeting Aβ peptides. A few immunotherapies are thought to provide some benefit. It is possible that a contributing factor to the responses of such therapies may be the presence of modified, or aberrant, Aβ peptides found in AD patients. These aberrations include the isomerization and epimerization of L-Asp and L-Ser residues to form D-Asp, L/D-isoAsp, and D-Ser residues, respectively. An effective methodology is essential to isolate all Aβ peptides and then to quantify and locate the aberrant amino acids. Modifications to Aβ peptides may elevate the deposition of Aβ plaques and/or contribute to the neurodegeneration in AD patients, and may alter the binding affinity to antibodies. Herein, we used immunoprecipitation to examine the binding affinity of four antibodies against 18 epimeric and/or isomeric Aβ peptides compared to wild type (all L) Aβ peptide. Tandem mass spectrometry was used as a detection method, which also was found to produce highly variable results for epimeric and/or isomeric Aβ.

摘要

细胞外淀粉样蛋白β(Aβ)肽的沉积是阿尔茨海默病(AD)的一个致病因素。人们花费了大量精力来开发针对 Aβ 肽的有效抗体或免疫疗法。一些免疫疗法被认为具有一定的益处。这些疗法之所以有反应,其原因之一可能是 AD 患者中存在修饰的或异常的 Aβ 肽。这些异常包括 L-Asp 和 L-Ser 残基分别异构化为 D-Asp、L/D-异天冬氨酸和 D-Ser 残基。因此,建立一种有效的方法来分离所有 Aβ 肽并定量和定位异常氨基酸是至关重要的。Aβ 肽的修饰可能会增加 Aβ 斑块的沉积,/或导致 AD 患者的神经退行性变,并可能改变与抗体的结合亲和力。在此,我们使用免疫沉淀法比较了四种针对 18 个异构和/或异构 Aβ 肽的抗体与野生型(均为 L)Aβ 肽的结合亲和力。串联质谱法被用作检测方法,但对于异构和/或异构 Aβ 肽,它也会产生高度可变的结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e212/10390520/5d7f2e3650f2/41598_2023_38788_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e212/10390520/5b499f51ca48/41598_2023_38788_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e212/10390520/399fbbd582b4/41598_2023_38788_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e212/10390520/62b37fd69213/41598_2023_38788_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e212/10390520/5d7f2e3650f2/41598_2023_38788_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e212/10390520/5b499f51ca48/41598_2023_38788_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e212/10390520/399fbbd582b4/41598_2023_38788_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e212/10390520/62b37fd69213/41598_2023_38788_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e212/10390520/5d7f2e3650f2/41598_2023_38788_Fig4_HTML.jpg

相似文献

1
Antibody binding of amyloid beta peptide epimers/isomers and ramifications for immunotherapies and drug development.淀粉样β肽差向异构体/异构体的抗体结合及其对免疫疗法和药物开发的影响。
Sci Rep. 2023 Jul 31;13(1):12387. doi: 10.1038/s41598-023-38788-1.
2
Variable fragmentation and ionization of amyloid-beta epimers and isomers.β-淀粉样蛋白差向异构体和异构体的可变片段化与电离
Anal Bioanal Chem. 2023 Nov;415(27):6799-6807. doi: 10.1007/s00216-023-04958-3. Epub 2023 Oct 3.
3
N-terminal heterogeneity of parenchymal and vascular amyloid-β deposits in Alzheimer's disease.阿尔茨海默病中实质和血管淀粉样-β 沉积物的 N 端异质性。
Neuropathol Appl Neurobiol. 2020 Dec;46(7):673-685. doi: 10.1111/nan.12637. Epub 2020 Jun 29.
4
Complete identification of all 20 relevant epimeric peptides in β-amyloid: a new HPLC-MS based analytical strategy for Alzheimer's research.全面鉴定β-淀粉样蛋白中所有 20 种相关差向异构体肽:阿尔茨海默病研究的一种新的基于 HPLC-MS 的分析策略。
Chem Commun (Camb). 2020 Feb 4;56(10):1537-1540. doi: 10.1039/c9cc09080k.
5
Rapid and selective separation of amyloid beta from its stereoisomeric point mutations implicated in neurodegenerative Alzheimer's disease.快速且选择性地分离淀粉样蛋白β与其涉及神经退行性阿尔茨海默病的立体异构点突变体。
Anal Chim Acta. 2021 Jun 8;1163:338506. doi: 10.1016/j.aca.2021.338506. Epub 2021 Apr 11.
6
Identification of peptides that specifically bind Abeta1-40 amyloid in vitro and amyloid plaques in Alzheimer's disease brain using phage display.利用噬菌体展示技术体外鉴定特异性结合β-淀粉样蛋白1-40以及阿尔茨海默病大脑中淀粉样斑块的肽段。
Neurobiol Dis. 2003 Oct;14(1):146-56. doi: 10.1016/s0969-9961(03)00105-0.
7
Pyroglutamation of amyloid-βx-42 (Aβx-42) followed by Aβ1-40 deposition underlies plaque polymorphism in progressing Alzheimer's disease pathology.淀粉样蛋白-βx-42(Aβx-42)的焦谷氨酸化,随后是 Aβ1-40 的沉积,是进行性阿尔茨海默病病理学中斑块多态性的基础。
J Biol Chem. 2019 Apr 26;294(17):6719-6732. doi: 10.1074/jbc.RA118.006604. Epub 2019 Feb 27.
8
Amyloid Plaque in the Human Brain Can Decompose from Aβ(1-40/1-42) by Spontaneous Nonenzymatic Processes.人脑中的淀粉样斑块可以通过自发的非酶过程从 Aβ(1-40/1-42)分解。
Anal Chem. 2016 Mar 1;88(5):2675-84. doi: 10.1021/acs.analchem.5b03891. Epub 2016 Feb 19.
9
Brain amyloid-beta fragment signatures in pathological ageing and Alzheimer's disease by hybrid immunoprecipitation mass spectrometry.通过杂交免疫沉淀质谱法分析病理性衰老和阿尔茨海默病中的脑淀粉样β片段特征
Neurodegener Dis. 2015;15(1):50-7. doi: 10.1159/000369465. Epub 2015 Jan 13.
10
Neuropathology and amyloid-β spectrum in a bapineuzumab immunotherapy recipient.接受 bapineuzumab 免疫疗法患者的神经病理学和淀粉样β谱
J Alzheimers Dis. 2011;24(2):315-25. doi: 10.3233/JAD-2011-101809.

引用本文的文献

1
Single-domain antibodies and aptamers drive new opportunities for neurodegenerative disease research.单域抗体和适体为神经退行性疾病研究带来新机遇。
Front Immunol. 2024 Aug 22;15:1426656. doi: 10.3389/fimmu.2024.1426656. eCollection 2024.
2
Immunolabeling-compatible PEGASOS tissue clearing for high-resolution whole mouse brain imaging.免疫标记兼容 PEGASOS 组织通透化用于高分辨率全鼠脑成像。
Front Neural Circuits. 2024 Apr 17;18:1345692. doi: 10.3389/fncir.2024.1345692. eCollection 2024.

本文引用的文献

1
Restoring the biological activity of crizanlizumab at physiological conditions through a pH-dependent aspartic acid isomerization reaction.通过依赖于 pH 值的天冬氨酸异构化反应,在生理条件下恢复 crizanlizumab 的生物学活性。
MAbs. 2023 Jan-Dec;15(1):2151075. doi: 10.1080/19420862.2022.2151075.
2
Immunotherapy for Alzheimer's disease: targeting β-amyloid and beyond.阿尔茨海默病的免疫疗法:靶向β-淀粉样蛋白及其他。
Transl Neurodegener. 2022 Mar 18;11(1):18. doi: 10.1186/s40035-022-00292-3.
3
Rapid and selective separation of amyloid beta from its stereoisomeric point mutations implicated in neurodegenerative Alzheimer's disease.
快速且选择性地分离淀粉样蛋白β与其涉及神经退行性阿尔茨海默病的立体异构点突变体。
Anal Chim Acta. 2021 Jun 8;1163:338506. doi: 10.1016/j.aca.2021.338506. Epub 2021 Apr 11.
4
Epitomic Characterization of the Specificity of the Anti-Amyloid Aβ Monoclonal Antibodies 6E10 and 4G8.抗淀粉样蛋白 Aβ 单克隆抗体 6E10 和 4G8 特异性的典型特征。
J Alzheimers Dis. 2018;66(3):1235-1244. doi: 10.3233/JAD-180582.
5
Anti-Amyloid-β Monoclonal Antibodies for Alzheimer's Disease: Pitfalls and Promise.抗淀粉样蛋白-β 单克隆抗体治疗阿尔茨海默病:陷阱与希望。
Biol Psychiatry. 2018 Feb 15;83(4):311-319. doi: 10.1016/j.biopsych.2017.08.010. Epub 2017 Aug 24.
6
Amyloid beta: structure, biology and structure-based therapeutic development.淀粉样β:结构、生物学和基于结构的治疗开发。
Acta Pharmacol Sin. 2017 Sep;38(9):1205-1235. doi: 10.1038/aps.2017.28. Epub 2017 Jul 17.
7
Aβ-Immunotherapeutic strategies: a wide range of approaches for Alzheimer's disease treatment.β-淀粉样蛋白免疫治疗策略:阿尔茨海默病治疗的广泛方法。
Expert Rev Mol Med. 2016 Jun 30;18:e13. doi: 10.1017/erm.2016.11.
8
Molecular basis for mid-region amyloid-β capture by leading Alzheimer's disease immunotherapies.主要的阿尔茨海默病免疫疗法捕获淀粉样β肽中段区域的分子基础。
Sci Rep. 2015 Apr 16;5:9649. doi: 10.1038/srep09649.
9
β-Amyloid peptides and amyloid plaques in Alzheimer's disease.阿尔茨海默病中的β-淀粉样肽与淀粉样斑块
Neurotherapeutics. 2015 Jan;12(1):3-11. doi: 10.1007/s13311-014-0313-y.
10
Monoclonal antibodies against Aβ42 fibrils distinguish multiple aggregation state polymorphisms in vitro and in Alzheimer disease brain.抗Aβ42原纤维的单克隆抗体可在体外和阿尔茨海默病大脑中区分多种聚集状态多态性。
J Biol Chem. 2014 Nov 14;289(46):32131-32143. doi: 10.1074/jbc.M114.594846. Epub 2014 Oct 3.